News Focus
News Focus
icon url

venus537

11/15/19 7:18 PM

#227063 RE: Will Lar #227058

You only expect $35-40 for a buyout???
icon url

Wiseman1

11/15/19 7:57 PM

#227070 RE: Will Lar #227058

AMGN has a PCSK9 Inhibitor Repatha that doesn't sell well. It's for high risk patients who did not achieve LDL goals with maximum statins. Want to push LDL to 30-50 range
icon url

dmlcento

11/16/19 7:05 AM

#227113 RE: Will Lar #227058

Will Lar, withe SP at $24 right now, there is no way in hell Amarin is getting bought for $35-40. No way!